Program targets reductions in surgical complications with INVOSTM Cerebral Oximetry Monitoring

The Problem

Cerebral Desaturation is COMMON

60-75% of high risk cardiac surgery patients experience cerebral desaturation1

Learn More

The Impact

Cerebral Desaturation is COSTLY

CABG patients experiencing prolonged desaturation have 3x greater risk for prolonged hospital stay >6 days1 costing up to $31,0002

Learn More

The Impact

Cerebral Desaturation is DEBILITATING

CABG surgery patients who experience prolonged desaturation have higher rates of major organ morbidity and mortality* than patients without prolonged desaturation.3

Learn More

The Solution

Facilities participating in Option 2 of the Outcomes Pledge Program, will collaborate with Medtronic to target 20% reduction in:

Surgical complications associated with cerebral desaturation (such as Major Organ Morbidity and Mortality) by implementing the INVOSTM System in the Operating Room


Click here

General Care Floor

MicrostreamTM Capnography

Click here

Intensive Care Unit

Puritan BennettTM Ventilation

Click here

1. Schoen J, Husemann L, Tiemeyer C, et al. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br J Anaesth. 2011;106 (6): 840–50.

2. Deschamps A, Lambert J, Couture P, et al. Reversal of decreases in cerebral saturation in high-risk cardiac surgery. J Cardiothorac Vasc Anesth. Available online 18 June 2013, ISSN 1053-0770.

3. AHRQ Brief, February, 2014. Available at hcup-us.ahrq.gov/reports/statbriefs/sb170-Operating-Room-Procedures-United-States-2011.pdf.

*Major Morbidity and Operative Mortality is a composite endpoint defined as having one or more of the following six complications: permanent stroke, reoperation for any reason, renal failure, prolonged ventilation > 24 hours, mediastinitis or death per STS version 2.81

** Adult Cardiac Surgery patients